We have recently shown, that LTB4 stimulates pancreatic cancer cell growth by activating ERK1/2; an effect inhibited by the unspecific LTB4 receptor antagonist, LY293111 (Tong et al, 2002, 2007). This evidence concerns the gene MAPK3 and familial pancreatic carcinoma.